Filing Details
- Accession Number:
- 0001683168-22-000673
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-03 20:15:22
- Reporting Period:
- 2022-02-01
- Accepted Time:
- 2022-02-03 20:15:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 704562 | Avid Bioservices Inc. | CDMO | Pharmaceutical Preparations (2834) | 953698422 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1723288 | B Richard Hancock | 2642 Michelle Drive, Suite 200 Tustin CA 92780 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2022-02-01 | 3,378 | $4.67 | 38,578 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2022-02-01 | 3,378 | $18.80 | 35,200 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Acquisiton | 2022-02-01 | 1,622 | $4.53 | 36,822 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2022-02-01 | 1,622 | $18.82 | 35,200 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-02-01 | 3,378 | $0.00 | 3,378 | $4.67 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-02-01 | 1,622 | $0.00 | 1,622 | $4.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 240,509 | 2027-11-27 | No | 4 | M | Direct | |
| 238,887 | 2026-05-07 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 15, 2021.
- Represents a weighted average sales price per share. These shares were sold at prices ranging from $18.21 to $19.21. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Represents a weighted average sales price per share. These shares were sold at prices ranging from $18.47 to $19.22. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Stock option granted to the reporting person on November 27, 2017 vested monthly over a three (3) period and was fully vested as of November 27, 2020.
- Stock option granted to the reporting person on May 7, 2019, vests in four (4) equal annual installments beginning May 7, 2020 and each year thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.
Billionaire Hedge Funds
